Contract award · W911NF22C0049
STTR PHASE II CONTRACT ENTITLED IODIDE FOR THE TREATMENT OF INFLUENZA AND OTHER STRESSES
Awarded to CHIMEROCYTE, INC. · CAGE 7XPK8
Latest reported total obligated
Not reported
Net observed obligations
$1.1M
Observed contract actions
2
Observed period
FY2022–FY2023
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorCHIMEROCYTE, INC.
CAGE7XPK8
CustomerDepartment of the Army
Performance locationSEATTLE, WASHINGTON, UNITED STATES
Procurement details
First observed actionSep 29, 2022
Latest observed actionJun 8, 2023
PSCAJ11
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
Annual observed obligations
FY2022
$542.4K
FY2023
$549.9K
Continue exploring
Ask Mimir about W911NF22C0049
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.